Arizona State Retirement System Chinook Therapeutics, Inc. Transaction History

Arizona State Retirement System

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 01, 2023	BUY	$18.66 - $38.58 $16,868 - $34,876	904 Added 7.51%	12,946 $497,000
Q1 2023 Apr 27, 2023	BUY	$21.53 - $26.8 $10,894 - $13,560	506 Added 4.39%	12,042 $278,000
Q4 2022 Feb 07, 2023	BUY	$18.63 - $27.35 $13,897 - $20,403	746 Added 6.91%	11,536 $302,000
Q3 2022 Nov 07, 2022	BUY	$17.51 - $23.37 $507 - $677	29 Added 0.27%	10,790 $212,000
Q2 2022 Jul 28, 2022	BUY	$12.59 - $18.8 $135,480 - $202,306	10,761 New	10,761 $188,000

234K

Ticker KDNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,896,300
Description
Chinook Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of precision medicines for kidney diseases. The company's lead clinical program is atrasentan, a Phase III endothelin receptor antagonist for the treatment of IgA nephropathy and other proteinuric glomerular diseases. ...

Get notified when there are updates to the investment portfolio of Arizona State Retirement System, based on Form 13F filings with the SEC.

Stay updated on Arizona State Retirement System with notifications on news.